A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults.
Kao CM, Rostad CA, Nolan LE, Peters E, Kleinhenz J, Sherman JD, Tippett A, Shih JWK, Yildirim I, Agbakoba V, Beresnev T, Ballou C, Kamidani S, Karmali V, Natrajan M, Scherer EM, Rouphael N, Anderson EJ.
Kao CM, et al. Among authors: ballou c.
J Infect Dis. 2024 Nov 15;230(5):1093-1101. doi: 10.1093/infdis/jiae148.
J Infect Dis. 2024.
PMID: 38536442
Clinical Trial.